...
首页> 外文期刊>Evidence-based nursing >Review: moderate weight loss reduces functional disability but does not reduce pain in obese patients with knee osteoarthritis
【24h】

Review: moderate weight loss reduces functional disability but does not reduce pain in obese patients with knee osteoarthritis

机译:评论:中等体重减轻可减轻肥胖性膝骨关节炎患者的功能障碍,但不能减轻疼痛

获取原文
获取原文并翻译 | 示例

摘要

QUESTIONIn obese patients with knee osteoarthritis (OA), does weight loss reduce pain and improve functional disability?METHODSData sources: MEDLINE (1966 to April 2006), EMBASE/ Excerpta Medica (1980 to April 2006), CINAHL (1982 to April 2006), Web of Science (1945 to April 2006), Scopus (1966 to May 2006), Cochrane Musculoskeletal Group's trials register, Cochrane Central Register of Controlled Trials, conference abstracts, and reference lists.Study selection and assessment: randomised controlled trials (RCTs) that evaluated any intervention reporting weight change as the only difference between the treatment and control groups in obese patients with knee OA. Concomitant treatments (eg, medication, exercise, or behavioural therapy) had to be identical in treatment and control groups. In studies of mixed patient populations (eg, hip and knee OA), only patients with knee OA were included. Quality assessment of individual studies was based on the 5-point Jadad scale. 4 RCTs (mean age range 63-69 y) met the selection criteria and had Jadad scores of 2 or 3. The interventions evaluated included combinations of a lowenergy diet (3.4 MJ/d); nutrition classes; cognitive behavioural therapy; and mazindol, an anorexigenic sympathomimetic drug, 0.5 mg/day.Outcomes: pain, self-reported disability, and patient global evaluation (Lequesne index).
机译:问题对于肥胖的膝关节骨关节炎(OA)患者,减肥能减轻疼痛并改善功能障碍吗?方法数据来源:MEDLINE(1966年至2006年4月),EMBASE / Excerpta Medica(1980年至2006年4月),CINAHL(1982年至2006年4月), Web of Science(1945年至2006年4月),Scopus(1966年至2006年5月),Cochrane肌肉骨骼研究小组的试验注册,Cochrane对照试验中心注册,会议摘要和参考文献清单。研究选择和评估:即随机对照试验(RCT)评估了任何报告体重改变的干预措施,作为肥胖和膝OA患者中治疗组和对照组之间的唯一区别。治疗组和对照组的伴随治疗(例如药物,运动或行为疗法)必须相同。在混合患者群体(例如髋和膝OA)的研究中,仅包括膝OA的患者。个别研究的质量评估基于5分Jadad量表。 4个RCT(平均年龄63-69岁)符合选择标准,Jadad评分为2或3。评估的干预措施包括低能量饮食(3.4 MJ / d)的组合;营养课;认知行为疗法;和mazindol(一种厌食性拟交感神经药),每天0.5 mg。结果:疼痛,自我报告的残疾和患者总体评价(Lequesne指数)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号